MTOR and cancer: It has been shown that the lack of miR-92a upregulates glycolytic and oxidative metabolism in cancer cells; however, the lack of miR-17 and miR-20a inhibits glycolytic and oxidative metabolism as well as mTOR pathways in cancer cells and increases the AMPK signaling pathway [31].